Serono and InDex in Ulcerative Colitis Deal
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 46 (Table of Contents)
Published: 4 Apr-2004
DOI: 10.3833/pdr.v2004.i46.816 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Serono and InDex Pharmaceuticals entered into licensing agreement for worldwide development and commercialization of InDex’s Kappaproct® for treating ulcerative colitis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS